BeOne Medicines (ONC) Gross Margin Growth (3y) (2020 - 2026)

BeOne Medicines (ONC) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -480.00

Historic Data

Download Data
DateValue
Mar 31, 2026 722.00
Dec 31, 2025 984.00
Sep 30, 2025 583.00
Jun 30, 2025 832.00
Mar 31, 2025 651.00
Dec 31, 2024 845.00
Sep 30, 2024 595.00
Jun 30, 2024 931.00
Mar 31, 2024 -1,123.00
Dec 31, 2023 437.00
Sep 30, 2023 1,087.00
Jun 30, 2023 567.00
Mar 31, 2023 891.00
Dec 31, 2022 1,227.00
Sep 30, 2022 2,035.00
Jun 30, 2022 -1,351.00
Mar 31, 2022 -167.00
Dec 31, 2021 -702.00
Sep 30, 2021 -690.00
Jun 30, 2021 -1,233.00